Determinants of transition states in MDMA self-administration
Determinants of transition states in MDMA self-administration
批准号:
8478273
负责人:
MICHAEL A. TAFFE
金额:
$1.27万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-01 至 2015-11-30
关键词:
AcuteAddressAgeAmphetaminesAnimal ExperimentationAnxietyAttenuatedAttitudeBehavioralBody TemperatureBrainCercopithecidaeChronicClinicalCocaineCognitiveDataDependenceDevelopmentDoseDrug abuseEmergency SituationEpidemiologyEtiologyExerciseExhibitsExposure toFeverFutureGoalsHeroinHigh PrevalenceHumanIceIndividualInterventionIntravenousLiteratureMaintenanceMedicalMethamphetamineMinorityModelingMonitorMotor ActivityNeuraxisPerceptionPerformancePharmaceutical PreparationsPharmacotherapyPhase I Clinical TrialsPhysiologic ThermoregulationPhysiologicalPrevalencePropertyPsychotherapyRattusRegimenReportingRiskRodentRodent ModelRoleRouteRunningSafetyScheduleSeizuresSelf AdministrationSerotoninSerotonin AgonistsSignal TransductionStudentsSurveysSymptomsTechniquesTemperatureTestingTimeTrainingWorkbaseclinically significantcohortdepressive symptomsdesigndisturbance in affectecstasyecstasy abuseexperienceinnovationinterestneurochemistryneurotoxicitynewsnovel therapeuticspre-clinical researchpreclinical studypublic health relevancerecreational drug usereinforcerresearch studyyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Epidemiological reports show that (1)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") continues to be used by large fractions of young adults. Studies have further suggested that up to 40 percent of users become at least temporarily dependent on MDMA, experienced users abuse an array of other substances and may abuse MDMA several times per week or even daily. It is also known that some Ecstasy users exhibit lasting cognitive and mood alterations, even years after discontinuing Ecstasy use. Nevertheless, in comparison with structurally related drugs such as amphetamine and methamphetamine minimal animal research has been devoted to understanding the determinants of repeated MDMA self-administration. Initial work has shown that MDMA appears to be a weak reinforcer compared with other psychomotor stimulants, thus additional study of factors which create a transition to frequent or compulsive MDMA use is needed. The hypothesis that differences in the self administration of MDMA are related to the increased serotonergic agonist properties of MDMA is supported by prior observations that drugs which increase serotonergic tone may decrease self- administration of psychomotor stimulants. Such work will not only contribute to understanding the development of MDMA/Ecstasy abuse but may generalize to understanding factors which influence which of a minority of individuals exposed to other psychomotor stimulants will eventually transition to dependence. The proposed studies will use rat intravenous self-administration models to test factors which may underlie a transition from casual to compulsive Ecstasy use. The experiments will first examine methodological variables such as training dose, route of administration and duration of access session that have not been systematically addressed for MDMA self-administration. Additional studies will examine situational factors intended to model the human user milieu (such as high ambient temperature and hyperthermia, running wheel activity and exposure to a serotonin-depleting high dose regimen of MDMA) which may facilitate a transition to dependence.
PUBLIC HEALTH RELEVANCE: Approximately 15-20 percent of young adults have used the recreational drug 3,4-methylenedioxy- methamphetamine (MDMA, known as "Ecstasy") and many of these users become dependent on Ecstasy while using; clinically significant symptoms of depression and anxiety, and poor cognitive performance can persist years after discontinuing Ecstasy use. Furthermore, in the US about 8,500 individuals per year have critical hyperthermia, seizure and other medical symptoms requiring emergency medical intervention after Ecstasy use. The proposed studies seek to determine situational and neurochemical factors which may increase use of this recreational drug and/or facilitate a transition from casual use to dependence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants
-
批准号:9932085
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2019
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants
-
批准号:10668867
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2016
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Prescription Opioid Addiction: Neurobiological Mechanisms
-
批准号:9024499
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2014
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Cannabinoid regulation of cognition
-
批准号:8484251
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2013
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Cannabinoid regulation of cognition
-
批准号:8739099
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2013
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Cannabinoid regulation of cognition
-
批准号:8657029
-
项目类别:
-
资助金额:$60.45万
-
财政年份:2013
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Cannabinoid regulation of cognition
-
批准号:8793181
-
项目类别:
-
资助金额:$70.64万
-
财政年份:2013
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Determinants of transition states in MDMA self-administration
-
批准号:8580927
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2011
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Determinants of transition states in MDMA self-administration
-
批准号:8063456
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2011
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Determinants of transition states in MDMA self-administration
-
批准号:8387029
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2011
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Determinants of transition states in MDMA self-administration
-
批准号:8773581
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2011
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Determinants of transition states in MDMA self-administration
-
批准号:8213525
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2011
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Immunopharmacotherapy for Methamphetamine Addiction
-
批准号:7668636
-
项目类别:
-
资助金额:$42.64万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Immunopharmacotherapy for Methamphetamine Addiction
-
批准号:8636303
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys
-
批准号:7670522
-
项目类别:
-
资助金额:$42.64万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Immunopharmacotherapy for Methamphetamine Addiction
-
批准号:8074409
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys
-
批准号:7857918
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys
-
批准号:8278018
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
Immunopharmacotherapy for Methamphetamine Addiction
-
批准号:8263782
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
CONSEQUENCES OF CHRONIC EXPOSURE TO DELTA9-THC IN MONKEYS
-
批准号:7651320
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2008
-
负责人:MICHAEL A. TAFFE
-
依托单位:
海外基金